Company news
Mayinglong Pharmaceutical Group Co., Ltd. news in 2026
Mayinglong Pharmaceutical Group Co., Ltd.'s news releases, calls and decks from 2026, newest first.
(600993)"Mayinglong Pharmaceutical Group Co., Ltd."Report for Q3 2026
October 29, 2026
Announcement on Convening the 2026 Semi-annual Performance Briefing
September 8, 2026
Announcement on Departure and Appointment of General Manager
August 25, 2026
Announcement on Implementation of Dividend Distribution for 2025
July 28, 2026
Announcement on the Listing and Trading of Restricted Shares from the Share Reform
July 16, 2026
Announcement on Obtaining Drug Registration Certificate by Subsidiary
July 10, 2026
Announcement on the Inclusion of the Company's Pharmaceutical Products in the "National Essential Medicines List"
July 9, 2026
Announcement on Attending the 2026 Collective Reception Day for Investors of Listed Companies in Hubei Jurisdiction
July 2, 2026
Announcement on Obtaining Drug Registration Certificate
June 25, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
June 17, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
June 9, 2026
Notice on Convening the 2025 Annual General Meeting
May 26, 2026
Announcement on Obtaining Drug Registration Certificate by Subsidiary
May 22, 2026
Announcement on Termination of the Transfer of Equity of Subsidiary Holding Company by the Holding Subsidiary
May 8, 2026
2025 Annual Report
April 24, 2026
Announcement on Transfer of Equity of Subsidiary Holding Company by the Holding Subsidiary
March 30, 2026
Announcement on Extending Usage Period for Credit Guarantee Limits for Some Subsidiaries
March 13, 2026